Completed NA INTERVENTIONAL 4-arm NCT04459741

HIV, Immune Activation and Salt Sensitive Hypertension (HISH)

Hypertension, Dietary Salt and Inflammation

Sponsor: Mulungushi University

Conditions HIV-1-infection Hypertension,Essential

Interventions Dietary salt (Sodium chloride)

Updated 4 times since 2020 Last updated: Jul 1, 2020 Started: Jan 2, 2019 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on HIV-1-infection and Hypertension,Essential, this trial is completed. The trial is conducted by Mulungushi University and has accumulated 4 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mulungushi University
University of Zambia
Vanderbilt University Medical Center

Data source: Mulungushi University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Livingstone, Zambia